hotspot -WSS

hotspot

author：explore 2025-09-28 00:52:10 - browse：66875

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： An outrageous hospital charge: I paid $710 for an hour of babysitting

Wikipedia

leisure time

WSS

Beware reading your test results before your doctor does

A letter from the executive editor: The 2023 STATUS List

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

VC firm RA Capital starts a new synthetic biology incubator

Use doctors trained outside the U.S. to ease the physician shortage

What affirmative action's end means to a medical student

entertainment

hotspot

leisure time

Heart attack and stroke risk calculators need revising

Biden to sign 'historic' executive order on how US military handles sexual assault cases

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Undocumented workers face uncertainty as immigration law takes effect in Florida

Wildfire smoke exposes gaps in outdoor worker protections

Dexcom's push to bring CGM to type 2 diabetes patients

Virginia high school admissions case could be legal follow

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Guidelines to prevent youth baseball injuries need more muscle

Ford recalls 870K F

explore

Fatty liver disease was alleviated by Lilly’s ‘triple

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Behind warning on Apellis’s eye drug lies a conflict of interest

As the dark side of IVF slowly comes into focus, even more transparency is needed

Canadians with cystic fibrosis outlive Americans by a decade

Wikipedia

leisure time

leisure time

hotspot